Effectiveness of dolutegravir in moderate severity COVID-19 patients: A single-center, randomized, double-blind, placebo-controlled trial
Abbaspour Kasgari$n$ et al., BioImpacts, doi:10.34172/bi.29952
https://c19early.org/abbaspourkasgari.html